Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SRTA · against 367 other Healthcare companies of similar size
Ranked #19 of 368 · scores higher than 94% of peers
Bars: peers in each 10-point band of the growth score33 peers with a growth score of 90–100, including SRTA · Click a bar to see the companies
Mainly thanks to its revenue growth, earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | SRTA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 382 reported | 136.1% | 2.8% | 96% | 33% | |
| Earnings per share growthHigher is better · 183 reported | Not reported | 3.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 361 reported | 10.4% | 3.7% | 73% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 2 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 609M USD | 99 | 91 | |
| 19 | 13.0B TWD (≈$402M) | 94 | 49 | |
| 19 | 257M USD | 94 | 55 | |
| 19 | 375M USD | 94 | 46 | |
| 19 | 20.8B THB (≈$581M) | 94 | 63 | |
| 19 | 393M USD | 94 | 61 | |
| 24 | 387M USD | 93 | 49 | |
| 25 | 287.6B KRW (≈$207M) | 92 | ||
| 25 | 4.6B CNY (≈$639M) | 92 | 68 | |
| 25 | 655M AUD (≈$432M) | 92 | 62 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score